The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy

Krystyna M. Wozniak, Ying Wu, James J. Vornov, Rena Lapidus, Rana Rais, Camilo Rojas, Takashi Tsukamoto, Barbara S. Slusher

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences